ArticleTherapeutics and clinical risk management2012

Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA).

Candace Y Hooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.